MARKET

RAD

RAD

Rite Aid
NYSE

Real-time Quotes | Nasdaq Last Sale

14.70
+0.47
+3.30%
After Hours: 14.73 +0.03 +0.20% 19:29 09/24 EDT
OPEN
14.10
PREV CLOSE
14.23
HIGH
14.79
LOW
13.98
VOLUME
2.41M
TURNOVER
--
52 WEEK HIGH
32.48
52 WEEK LOW
8.86
MARKET CAP
809.78M
P/E (TTM)
-19.5349
1D
5D
1M
3M
1Y
5Y
Rite Aid Statement on CDC Recommendation Regarding COVID-19 Vaccine "Boosters"
Today the Centers for Disease Control and Prevention (CDC) concurred with previous recommendations made by the Food and Drug Administration (FDA) and the Advisory Committee on Immunization Practices (ACIP), officially recommending "booster" doses of the Pf...
Business Wire · 1d ago
Bartell Drugs Announces Partnership With Uber To Expand On-demand Delivery Throughout Western Washington
Today, Bartell Drugs (Bartell's) announced a new partnership with Uber Technologies, Inc. (NYSE: UBER) to offer delivery of Bartell's products in the Puget Sound region through Uber Eats. This partnership will allow customers to purchase essential healthca...
PR Newswire · 1d ago
Rite Aid Partners With Uber Eats to Expand On-Demand Delivery Nationwide; No Terms Disclosed
Partnership will offer quick delivery and improved access to essential items Today,Rite Aid (NYSE:RAD) announced the expansion of their partnership with Uber Technologies, Inc. (NYSE:UBER) to offer delivery of Rite Aid
Benzinga · 1d ago
Rite Aid (RAD) Q2 Loss Narrower Than Expected, Revenues Miss
Despite high costs, Rite Aid's (RAD) fiscal second-quarter results have been aided by increased demand as well as strength in Elixir and the Retail Pharmacy unit.
Zacks · 1d ago
JPMorgan Small Cap Sustainable Leaders Fund Buys Arena Pharmaceuticals Inc, Unifi Inc, ...
GuruFocus News · 1d ago
Rite Aid slumps 8% on Q2 miss, FY revenue revised upward
Rite Aid (RAD -7.5%) reports revenue surge of 2.2% to $6.11B, the increase was driven by growth at the Retail Pharmacy Segment, partially offset by a decline at the Pharmacy Services Segment.
Seekingalpha · 2d ago
Rite Aid Stock Must Hold This Key Support Level After Dip on Earnings
Rite Aid stock has one key support level left before more potential downside. Investors trading the stock should keep that level in mind.
TheStreet.com · 2d ago
Rite Aid Shares Crumble After Expecting Wider Annual Net Loss For Fiscal 2022
Rite Aid Corporation (NYSE: RAD) 
Benzinga · 2d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of RAD. Analyze the recent business situations of Rite Aid through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Underperform

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average RAD stock price target is 12.00 with a high estimate of 13.00 and a low estimate of 11.00.
EPS
Institutional Holdings
Institutions: 331
Institutional Holdings: 50.45M
% Owned: 91.58%
Shares Outstanding: 55.09M
TypeInstitutionsShares
Increased
51
4.27M
New
26
585.75K
Decreased
50
3.17M
Sold Out
44
2.82M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Drug Retailers
-0.10%
Food & Drug Retailing
+0.15%
Key Executives
Non-Executive Chairman/Independent Director
Bruce Bodaken
President/Chief Executive Officer/Director
Heyward Donigan
Chief Financial Officer/Executive Vice President
Matthew Schroeder
Chief Operating Officer
Lance Neill
Chief Human Resource Officer
Jessica Kazmaier
Executive Vice President/Chief Information Officer
Justin Mennen
Executive Vice President/General Counsel/Secretary
Paul Gilbert
Executive Vice President
Jocelyn Konrad
Senior Vice President/Chief Marketing Officer
Erik Keptner
Chief Accounting Officer
Brian Hoover
Other
Andre Persaud
Independent Director
Elizabeth Burr
Independent Director
Bari Harlam
Independent Director
Robert Knowling
Independent Director
Kevin Lofton
Independent Director
Louis Miramontes
Independent Director
Arun Nayar
Independent Director
Katherine Quinn
Declaration Date
Dividend Per Share
Ex-Div Date
10/07/1999
Dividend USD 0.115
10/14/1999
06/30/1999
Dividend USD 0.115
07/15/1999
04/07/1999
Dividend USD 0.115
04/15/1999
01/13/1999
Dividend USD 0.115
01/15/1999
About RAD
Rite Aid Corporation is a healthcare company that operates retail drugstore chain. The Company is principally engaged in providing its service to customers and communities through various programs. Its business segments include Retail Pharmacy segment and Pharmacy Services segment. Retail Pharmacy segment sells brand and generic prescription drugs and various other pharmacy services, as well as front-end products, including health and beauty aids, personal care products and seasonal merchandise. Its Retail Pharmacy segment operates approximately 2,500 retail pharmacy locations across 19 states. Pharmacy Services segment provides a range of pharmacy benefit services through Elixir. Elixir also offers integrated mail-order and specialty pharmacy services through Elixir Pharmacy. The Pharmacy Services segment provides both transparent and traditional pharmacy benefit management (PBM) options through its Elixir PBM. The Company's clients include employers, insurance companies and unions.

Webull offers kinds of Rite Aid Corporation stock information, including NYSE:RAD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RAD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RAD stock methods without spending real money on the virtual paper trading platform.